Compare companies
Selected: 2 of 5
Key figures side by side
| Measure | Glaxosmithkline AS2025 | Pfizer AS2025 |
|---|---|---|
| Sector and size | Handel · Large | Handel · Large |
| Score | 52 rank 10,659 of 22,949 | 54 rank 9,924 of 22,949 |
| Operating revenue | 1,264 MNOKmedian 1,119 MNOK | 1,075 MNOKmedian 1,119 MNOK |
| Operating margin | 3.0%median 2.5% | 1.9%median 2.5% |
| Profit margin | 3.1%median 2.5% | 3.1%median 2.5% |
| Return on assets | 9.7%median 10.2% | 4.2%median 10.2% |
| Equity ratio | 28.0%median 30.9% | 39.5%median 30.9% |
| Debt-to-equity | 2.57median 2.23 | 1.53median 2.23 |
| Current ratio | 1.11median 1.30 | 1.76median 1.30 |
| Revenue growth | 21.6%median 6.9% | 10.3%median 6.9% |
| Employees (Enhetsregisteret) | 74 | 58 |
The median is each company's own comparison group: same sector, financial year and size group. Source: Brønnøysund Register Centre.
Indications based on the latest annual accounts from open data. Not investment or financial advice.
